Clinical trial
Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients…
NCT00206453 · Baylor Breast Care Center, Other · Terminated
Key facts
| NCT number | NCT00206453 |
|---|---|
| Title | Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer |
| Official title | An Extension Phase II Study of the Clinical and Biologic Effects of Docetaxel (Taxotere) in Patients With Locally Advanced Breast Cancer |
| Lead sponsor | Baylor Breast Care Center, Other |
| Collaborators | United States Department of Defense U.S. Fed |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Taxotere |
| Enrollment | 25 |
| Start date | Jan 1, 2002 |
| Primary completion | Jan 1, 2005 |
| Completion | Jan 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Feb 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: